Adalat Overdose

If you believe you may have overdosed on Adalat CC, seek immediate medical attention. Some symptoms of an Adalat CC overdose include dizziness, fainting, and difficulty breathing. Treating a recent overdose may involve pumping the stomach or administering certain medications. Treatment may also involve supportive care, which consists of treating the symptoms that occur as a result of the overdose.

 

Adalat Overdose: An Overview

Adalat CC® (nifedipine) is a prescription medication known as a calcium channel blocker. It is used to treat high blood pressure (hypertension). The effects of an Adalat CC overdose will vary depending on a number of factors, including how much Adalat CC was taken and whether it was taken with any other medicines, alcohol, and/or street drugs.
 
If you happen to overdose on Adalat CC, seek immediate medical attention.
 

Symptoms of an Adalat Overdose

Adalat CC overdose symptoms may include:
 
  • Low blood pressure (hypotension)
  • Loss of consciousness
  • An irregular heart rhythm (arrhythmia)
  • Fluid in the lungs.
     
This may cause signs or symptoms that include:
 
  • Lightheadedness
  • Dizziness
  • Fainting
  • Difficulty breathing.
     

Treatment for an Adalat Overdose

The treatment for an Adalat CC overdose will vary.
 If the overdose was recent, a healthcare provider may use certain medicines or place a tube into the stomach to "pump the stomach." Treatment may also involve supportive care. This type of care consists of treating the symptoms that occur as a result of the overdose. For example, supportive treatment options may include:
 
  • Fluids through an intravenous line (IV)
  • Medications to increase blood pressure or correct an arrhythmia
  • Other treatments based on the complications that occur
  • Close monitoring of the heart and lungs.
     
It is important that you seek medical attention immediately if you believe that you may have overdosed on Adalat CC.
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;